April 30, 2009 / 6:20 AM / 10 years ago

JCL Bioassay <2190.OJ>-2008/09 parent results

   April 30 (Reuters) -
                JCL BIOASSAY CORP
                PARENT-ONLY FINANCIAL HIGHLIGHTS
 (in billions of yen unless specified)
               Year ended      Year ended      Year to        Six months to
               Mar 31, 2009    Mar 31, 2008    Mar 31, 2010    Sep 30, 2009
               LATEST          YEAR-AGO        COMPANY         COMPANY   
               RESULTS         RESULTS         FORECASTS       H1 FORECASTS
 Sales               2.49            2.31            2.58            1.02   
                 (+7.9 pct)      (+2.7 pct)         (+3.5%)              
 Operating            502 mln         361 mln         558 mln         155 mln
                (+39.0 pct)     (-17.2 pct)        (+11.2%)              
 Recurring            444 mln         332 mln         524 mln         140 mln
                (+33.6 pct)     (-20.4 pct)        (+18.0%)              
 Net                  265 mln         232 mln         301 mln          52 mln
                (+14.5 pct)      (-6.6 pct)        (+13.3%)              
 EPS                  Y102.99          Y91.06          Y91.10          Y15.86
 Annual div            Y10.00                          Y10.00               
  -Q4 div              Y10.00                          Y10.00               
 NOTE - JCL Bioassay Corp is the full company name.
 If there is no Q1 or Q3 dividend, Q2 will in most cases
correspond to the first-half dividend and Q4 to the second-half
dividend announced before a new corporate law in 2006 allowed
companies to pay and report dividends on a quarterly basis.
 For latest earnings estimates made by Toyo Keizai, please
double click on 2190.TK1.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below